Kitov Submits New Drug Application to FDA for KIT-302


July 31, 2017 (STL.News) The company expects that within 60 days the FDA will determine whether the NDA is complete and acceptable for filing. We are pleased with the dedicated, professional work of our staff, investigators, and CROs.  We look forward to working with FDA as it reviews the NDA, stated J. Paul Waymack, M.D., [ ] The post Kitov Submits New Drug Application to FDA for KIT-302 appeared first on STL News.
http://bit.ly/2tXLBfI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: